The following slide deck was published by ShockWave Medical, Inc. in conjunction with their 2022 Q1 earnings call. Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with our readers new transcript-related developments. Thanks, SA Transcripts Team.
Photographer Camden Thrasher was shooting a demonstration of US Navy fighter jets when he captured a remarkable close-up photo of a plane creating “shockwave lines” as it approached the speed of sound. The motorsport and aviation photographer was at the EAA Airventure airshow featuring the VFA-106 Gladiators (officially...
One of the simplest pleasures in “Slay the Spire” is the ability to play as many cards as possible with complete disregard for the energy counter. Though the Silent may be the first to come to mind when card spamming is brought up, there’s also a way for the Ironclad to pepper monsters with attacks by using a specialized deck that abuses Energy generation without sacrificing damage output.
Today we are with Dr. Robert Zahn at Zahn Chiropractic Clinic located at 1005 N Southland Park Drive in Shreveport to discuss a new therapy technique that uses shockwave therapy to help alleviate pain. These shockwaves come from soundwaves that not only work as a treatment, but it’s also a great diagnostic tool to help pinpoint the source of your pain.
The release of Shockwave C² is a similar event to TAVRs for Edwards Lifesciences. In February 2021, the FDA approved ShockWave Medical, Inc.'s (NASDAQ:SWAV) novel Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave C2 Coronary Intravascular Lithotripsy (IVL) Catheter. It is not important to understand the device and how it is used, but it is important to see huge revenue growth thanks to sales of this product here in 2022.
The Santa Clara, California-based company reported profits of $14.5 million, or 39¢ per share, on sales of $93.6 million for the three months ended March 31, for a bottom-line gain from the year prior on sales growth of 193.5%. Earnings per share were 25¢ ahead of The Street, where...